Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Abdelrahim A Sadek, Mohammed H Hassan & Nesreen A Mohammed. (2018) Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years. Neuropsychiatric Disease and Treatment 14, pages 2551-2561.
Read now
Read now
Cristina Romani. (2018) Cognitive impairments in inherited metabolic diseases: Promises and challenges. Cognitive Neuropsychology 35:3-4, pages 113-119.
Read now
Read now
Cristina Romani, Anita MacDonald, Sara De Felice & Liana Palermo. (2018) Speed of processing and executive functions in adults with phenylketonuria: Quick in finding the word, but not the ladybird. Cognitive Neuropsychology 35:3-4, pages 171-198.
Read now
Read now
Zoë W. Hawks, Michael J. Strube, Neco X. Johnson, Dorothy K. Grange & Desirée A. White. (2018) Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria. Developmental Neuropsychology 43:3, pages 207-218.
Read now
Read now
Claudia Caprile, Jaume Campistol, Laura Puigcerver, Alfonso-Pablo Gutiérrez-Mata, Itziar Alonso-Colmenero, Roser Colomé & Jordi Navarra. (2017) Subtle visuomotor deficits and reduced benefit from practice in early treated phenylketonuria. Journal of Clinical and Experimental Neuropsychology 39:10, pages 931-940.
Read now
Read now
Tara Riddle & Julie Suhr. (2012) Extension of the Contingency Naming Test to Adult Assessment: Psychometric Analysis in a College Student Sample. The Clinical Neuropsychologist 26:4, pages 609-625.
Read now
Read now
Pia Banerjee, Dorothy
K. Grange, Robert
D. Steiner & Desirée
A. White. (2011) Executive Strategic Processing During Verbal Fluency Performance in Children with Phenylketonuria. Child Neuropsychology 17:2, pages 105-117.
Read now
Read now
Fiona M. Lewis, David J. Coman & Bruce E. Murdoch. (2010) LANGUAGE SKILLS IN A CHILD WITH LEBER HEREDITARY OPTIC NEUROPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Hematology and Oncology 27:8, pages 626-635.
Read now
Read now
Articles from other publishers (74)
Mitzie L. Grant, Elaina R. Jurecki, Shawn E. McCandless, Stephen M. Stahl, Deborah A. Bilder, Amarilis Sanchez-Valle & David Dimmock. (2023) Neuropsychiatric Function Improvement in Pediatric Patients with Phenylketonuria. The Journal of Pediatrics 260, pages 113526.
Crossref
Crossref
Agnese De Giorgi, Francesca Nardecchia, Filippo Manti, Jaume Campistol & Vincenzo Leuzzi. (2023) Neuroimaging in early-treated phenylketonuria patients and clinical outcome: A systematic review. Molecular Genetics and Metabolism 139:2, pages 107588.
Crossref
Crossref
Shawn E. Christ, Hayley E. Clocksin, Maia Zalik, Benjamin D. Goodlett, Stephanie J. Sacharow & Emily E. Abbene. (2023) Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox. Molecular Genetics and Metabolism 139:1, pages 107579.
Crossref
Crossref
Hayley E. Clocksin, Emily E. Abbene & Shawn Christ. (2022) A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria. Journal of the International Neuropsychological Society, pages 1-10.
Crossref
Crossref
Barbara K. Burton, Álvaro Hermida, Amaya Bélanger-Quintana, Heather Bell, Kendra J. Bjoraker, Shawn E. Christ, Mitzie L. Grant, Cary O. Harding, Stephan C.J. Huijbregts, Nicola Longo, Markey C. McNuttIIII, Mina D. Nguyen-Driver, André L. Santos Pessoa, Júlio César Rocha, Stephanie Sacharow, Amarilis Sanchez-Valle, H. Serap Sivri, Jerry Vockley, Mark Walterfang, Sarah Whittle & Ania C. Muntau. (2022) Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach. Molecular Genetics and Metabolism 137:1-2, pages 114-126.
Crossref
Crossref
Deborah A. Bilder, Georgianne L. Arnold, David Dimmock, Mitzie L. Grant, Darren Janzen, Nicola Longo, Mina Nguyen‐Driver, Elaina Jurecki, Markus Merilainen, Gianni Amato & Susan Waisbren. (2021) Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria. American Journal of Medical Genetics Part A 188:3, pages 768-778.
Crossref
Crossref
Elisabetta Anna Tendi, Maria Guarnaccia, Giovanna Morello & Sebastiano Cavallaro. (2022) The Utility of Genomic Testing for Hyperphenylalaninemia. Journal of Clinical Medicine 11:4, pages 1061.
Crossref
Crossref
Iryna Babik. (2022) From Hemispheric Asymmetry through Sensorimotor Experiences to Cognitive Outcomes in Children with Cerebral Palsy. Symmetry 14:2, pages 345.
Crossref
Crossref
Philip David Zelazo, Stella F. Lourenco, Michael C. Frank, Jed T. Elison, Robert K. Heaton, Henry M. Wellman, Jerry Slotkin, Maria Kharitonova & J. Steven Reznick. (2021) Measurement of Cognition for the National Children's Study. Frontiers in Pediatrics 9.
Crossref
Crossref
Hayley E. Clocksin, Zoë W. Hawks, Desirée A. White & Shawn E. Christ. (2021) Inter- and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU). Molecular Genetics and Metabolism 132:1, pages 11-18.
Crossref
Crossref
Kristina Aldridge, Kimberly K. Cole, Amanda J. Moffitt Gunn, Dawn Peck, Desirée A. White & Shawn E. Christ. (2020) The effects of early-treated phenylketonuria on volumetric measures of the cerebellum. Molecular Genetics and Metabolism Reports 25, pages 100647.
Crossref
Crossref
Roeland A. F. Evers, Danique Vliet & Francjan J. Spronsen. (2019) Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approach. Journal of Inherited Metabolic Disease 43:2, pages 189-199.
Crossref
Crossref
Corinna A. Moro & Wendy Hanna-Rose. 2020. Animal Models of Human Birth Defects. Animal Models of Human Birth Defects
225
244
.
Cristina Romani, Filippo Manti, Francesca Nardecchia, Federica Valentini, Nicoletta Fallarino, Claudia Carducci, Sabrina De Leo, Anita MacDonald, Liana Palermo & Vincenzo Leuzzi. (2019) Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Killian Ashe, Wendy Kelso, Sarah Farrand, Julie Panetta, Tim Fazio, Gerard De Jong & Mark Walterfang. (2019) Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments. Frontiers in Psychiatry 10.
Crossref
Crossref
Marie Canton, Didier Le Gall, François Feillet, Chrystele Bonnemains & Arnaud Roy. (2019) Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches. Journal of the International Neuropsychological Society 25:6, pages 624-643.
Crossref
Crossref
R. Feldmann, J. Osterloh, S. Onon, J. Fromm, F. Rutsch & J. Weglage. (2019) Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up. Molecular Genetics and Metabolism 126:3, pages 246-249.
Crossref
Crossref
María Julieta González, Mónica Rebollo Polo, Pablo Ripollés, Rosa Gassió, Aída Ormazabal, Cristina Sierra, Roser Colomé Roura, Rafael Artuch & Jaume Campistol. (2018) White matter microstructural damage in early treated phenylketonuric patients. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Gina A. Montoya Parra, Rani H. Singh, Aysun Cetinyurek-Yavuz, Mirjam Kuhn & Anita MacDonald. (2018) Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Vincent M Isabella, Binh N Ha, Mary Joan Castillo, David J Lubkowicz, Sarah E Rowe, Yves A Millet, Cami L Anderson, Ning Li, Adam B Fisher, Kip A West, Philippa J Reeder, Munira M Momin, Christopher G Bergeron, Sarah E Guilmain, Paul F Miller, Caroline B Kurtz & Dean Falb. (2018) Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nature Biotechnology 36:9, pages 857-864.
Crossref
Crossref
A. Bartus, F. Palasti, E. Juhasz, E. Kiss, E. Simonova, Cs. Sumanszki & P. Reismann. (2018) The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients. Metabolic Brain Disease 33:5, pages 1609-1615.
Crossref
Crossref
Joseph Leung, Caroline Selvage, Taryn Bosdet, Jennifer Branov, Annie Rosen-Heath, Carole Bishop, Sandra Sirrs & Gabriella Horvath. (2018) Salivary serotonin does not correlate with central serotonin turnover in adult phenylketonuria (PKU) patients. Molecular Genetics and Metabolism Reports 15, pages 100-105.
Crossref
Crossref
Natalia García Restrepo, Jorge Hernández G., María Laura Londoño & Richard Muriel Ramírez. (2018) Deficiencia de fenilalanina hidroxilasa : espectro clínico y estado actual del diagnóstico en Colombia.. Biosalud 17:1, pages 49-64.
Crossref
Crossref
Gabriella Santangelo, Fausta Piscopo, Franco Santangelo & Luigi Trojano. (2017) Neuropsychological profile in parents of adult phenylketonuria patients. Neurological Sciences 39:1, pages 161-164.
Crossref
Crossref
Fatma Rabah, Khalid Al-Thihli, Mohamed El-Naggari & Ibtisam B. Elnour. (2017) A child with phenylketonuria and focal segmental glomerulosclerosis, the bright side of proteinuria. Metabolic Brain Disease 32:4, pages 1119-1121.
Crossref
Crossref
Juliette Bouchereau, Julie Leduc-Leballeur, Samia Pichard, Apolline Imbard, Jean-François Benoist, Marie-Thérèse Abi Warde, Jean-Baptiste Arnoux, Valérie Barbier, Anaïs Brassier, Pierre Broué, Aline Cano, Brigitte Chabrol, Gilles Damon, Claire Gay, Isabelle Guillain, Florence Habarou, Delphine Lamireau, Chris Ottolenghi, Laetitia Paermentier, Frédérique Sabourdy, Guy Touati, Hélène Ogier de Baulny, Pascale de Lonlay & Manuel Schiff. (2017) Neurocognitive profiles in MSUD school-age patients. Journal of Inherited Metabolic Disease 40:3, pages 377-383.
Crossref
Crossref
A. Simons, F. Eyskens, I. Glazemakers & D. van West. (2016) Can psychiatric childhood disorders be due to inborn errors of metabolism?. European Child & Adolescent Psychiatry 26:2, pages 143-154.
Crossref
Crossref
Elana Pinchefsky & Michael Shevell. 2017. Handbook of DSM-5 Disorders in Children and Adolescents. Handbook of DSM-5 Disorders in Children and Adolescents
19
55
.
Shawn E. Christ, Mason H. Price, Kimberly E. Bodner, Christopher Saville, Amanda J. Moffitt & Dawn Peck. (2016) Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Molecular Genetics and Metabolism 118:1, pages 3-8.
Crossref
Crossref
. 2016. Diagnostic Imaging: Brain. Diagnostic Imaging: Brain
836
837
.
Anna Hood, Jerrel Rutlin, Joshua S. Shimony, Dorothy K. Grange & Desiree A. White. 2017. JIMD Reports, Volume 33. JIMD Reports, Volume 33
41
47
.
Marion Deon, Angela Sitta, Jessica L. Faverzani, Gillian B. Guerreiro, Bruna Donida, Desirèe P. Marchetti, Caroline P. Mescka, Graziela S. Ribas, Adriana S. Coitinho, Moacir Wajner & Carmen R. Vargas. (2015) Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. International Journal of Developmental Neuroscience 47:Part_B, pages 259-265.
Crossref
Crossref
Khaled Saad, Yasser Elserogy, Ahmed A. Abdel rahman, Abdulrahman Abdullah Al-Atram, Ismail L. Mohamad, Tarek T. H. ElMelegy, Geir Bjørklund & Amira A. El-Houfy. (2015) ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt. Acta Neurologica Belgica 115:4, pages 657-663.
Crossref
Crossref
Marion Deon, Sharon S. Landgraf, Jessica F. Lamberty, Dinara J. Moura, Jenifer Saffi, Moacir Wajner & Carmen R. Vargas. (2015) Protective effect of L-carnitine on Phenylalanine-induced DNA damage. Metabolic Brain Disease 30:4, pages 925-933.
Crossref
Crossref
Geertje B. Liemburg, Rianne Jahja, Francjan J. van Spronsen, Leo M.J. de Sonneville, Jaap J. van der Meere, Annet M. Bosch, Carla E.M. Hollak, M. Estela Rubio-Gozalbo, Martijn C.G.J. Brouwers, Floris C. Hofstede, Maaike C. de Vries, Mirian C.H. Janssen, Ans T. van der Ploeg, Janneke G. Langendonk & Stephan C.J. Huijbregts. (2015) Is BRIEF a useful instrument in day to day care of patients with phenylketonuria?. Molecular Genetics and Metabolism 114:3, pages 425-430.
Crossref
Crossref
Dionísia Aparecida Cusin Lamônica, Mariana Germano Gejão & Fernanda da Luz Anastácio-Pessan. (2015) Fenilcetonúria e habilidades de leitura e escrita. Revista CEFAC 17:1, pages 143-150.
Crossref
Crossref
Anna Hood, Jo Ann V. Antenor-Dorsey, Jerrel Rutlin, Tamara Hershey, Joshua S. Shimony, Robert C. McKinstry, Dorothy K. Grange, Shawn E. Christ, Robert Steiner & Desiree A. White. (2015) Prolonged exposure to high and variable phenylalanine levels over the lifetime predicts brain white matter integrity in children with phenylketonuria. Molecular Genetics and Metabolism 114:1, pages 19-24.
Crossref
Crossref
Esther Imperlini, Stefania Orrù, Claudia Corbo, Aurora Daniele & Francesco Salvatore. (2014)
Altered brain protein expression profiles are associated with molecular neurological dysfunction in the
PKU
mouse model
. Journal of Neurochemistry 129:6, pages 1002-1012.
Crossref
Crossref
Anna Hood, Dorothy K. Grange, Shawn E. Christ, Robert Steiner & Desirée A. White. (2014) Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria. Molecular Genetics and Metabolism 111:4, pages 445-451.
Crossref
Crossref
Julien Baruteau, Omar Nyabi, Mustapha Najimi, Maarten Fauvart & Etienne Sokal. (2014) Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase. Journal of Pediatric Endocrinology and Metabolism 27:9-10.
Crossref
Crossref
Michèle Carlier & Pierre L. Roubertoux. 2014. Behavior Genetics of Cognition Across the Lifespan. Behavior Genetics of Cognition Across the Lifespan
69
101
.
Martijn J de Groot, Marieke Hoeksma, Dirk-Jan Reijngoud, Harold W de Valk, Anne MJ Paans, Pieter JJ Sauer & Francjan J van Spronsen. (2013) Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet Journal of Rare Diseases 8:1.
Crossref
Crossref
Kellen R. SimonRosane M. dos SantosGiselli ScainiDaniela D. LeffaAdriani P. DamianiCamila B. FurlanettoJéssica L. MachadoJosé H. CararoTamires P. MacanEmilio L. StreckGustavo C. FerreiraVanessa M. AndradePatrícia F. Schuck. (2013)
DNA damage induced by phenylalanine and its analogue
p
-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia
. Biochemistry and Cell Biology 91:5, pages 319-324.
Crossref
Crossref
M. Stevenson & N. McNaughton. (2013) A comparison of phenylketonuria with attention deficit hyperactivity disorder: Do markedly different aetiologies deliver common phenotypes?. Brain Research Bulletin 99, pages 63-83.
Crossref
Crossref
Colleen Dockstader, William Gaetz, Eric Bouffet, Uri Tabori, Frank Wang, Stefan R. Bostan, Suzanne Laughlin & Donald J. Mabbott. (2013) Neural correlates of delayed visual–motor performance in children treated for brain tumours. Cortex 49:8, pages 2140-2150.
Crossref
Crossref
Noelle E. Carlozzi, David S. Tulsky, Robert V. Kail & Jennifer L. Beaumont. (2013) VI. NIH TOOLBOX COGNITION BATTERY (CB): MEASURING PROCESSING SPEED. Monographs of the Society for Research in Child Development 78:4, pages 88-102.
Crossref
Crossref
Teresa D. Douglas, Hyder A. Jinnah, Douglas Bernhard & Rani H. Singh. (2013) The effects of sapropterin on urinary monoamine metabolites in phenylketonuria. Molecular Genetics and Metabolism 109:3, pages 243-250.
Crossref
Crossref
Jo Ann V. Antenor-Dorsey, Tamara Hershey, Jerrel Rutlin, Joshua S. Shimony, Robert C. McKinstry, Dorothy K. Grange, Shawn E. Christ & Desirée A. White. (2013) White matter integrity and executive abilities in individuals with phenylketonuria. Molecular Genetics and Metabolism 109:2, pages 125-131.
Crossref
Crossref
Deborah A. Bilder, Barbara K. Burton, Hilary Coon, Lauren Leviton, James Ashworth, Bridget D. Lundy, Hazel Vespa, Amanda V. Bakian & Nicola Longo. (2013) Psychiatric symptoms in adults with phenylketonuria. Molecular Genetics and Metabolism 108:3, pages 155-160.
Crossref
Crossref
J. Weglage, J. Fromm, A. van Teeffelen-Heithoff, H.E. Möller, B. Koletzko, T. Marquardt, F. Rutsch & R. Feldmann. (2013) Neurocognitive functioning in adults with phenylketonuria: Results of a long term study. Molecular Genetics and Metabolism 110, pages S44-S48.
Crossref
Crossref
A. M. Das, K. Goedecke, U. Meyer, N. Kanzelmeyer, S. Koch, S. Illsinger, T. Lücke, H. Hartmann, K. Lange, H. Lanfermann, L. Hoy & X.-Q. Ding. 2014. JIMD Reports - Case and Research Reports, Volume 13. JIMD Reports - Case and Research Reports, Volume 13
149
158
.
Hope Schreiber. (2012) Pilot Study on Executive Function and Adaptive Skills in Adolescents and Young Adults With Mitochondrial Disease. Journal of Child Neurology 27:12, pages 1506-1516.
Crossref
Crossref
Colin J. O’SheaJennifer L. SloanEdythe A. Wiggs, Maryland PaoAndrea Gropman, Eva H. Baker, Irini ManoliCharles P. VendittiJoseph Snow. (2012) Neurocognitive Phenotype of Isolated Methylmalonic Acidemia. Pediatrics 129:6, pages e1541-e1551.
Crossref
Crossref
Roland Kreis. 2012. Neural Metabolism In Vivo. Neural Metabolism In Vivo
1117
1134
.
Krista S. Viau, Heidi J. Wengreen, Sharon L. Ernst, Nancy L. Cantor, Larissa V. Furtado & Nicola Longo. (2011) Correlation of age‐specific phenylalanine levels with intellectual outcome in patients with phenylketonuria. Journal of Inherited Metabolic Disease 34:4, pages 963-971.
Crossref
Crossref
Wei Wu, Diying Sheng, Jie Shao & Zhengyan Zhao. (2011) Mental and motor development and psychosocial adjustment of Chinese children with phenylketonuria. Journal of Paediatrics and Child Health 47:7, pages 441-447.
Crossref
Crossref
JAUME CAMPISTOL, ROSA GASSIÓ, RAFAEL ARTUCH & Ma ANTONIA VILASECA. (2011) Neurocognitive function in mild hyperphenylalaninemia. Developmental Medicine & Child Neurology 53:5, pages 405-408.
Crossref
Crossref
Barbara K. Burton & Lauren Leviton. (2010) Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU). Molecular Genetics and Metabolism 101:2-3, pages 146-148.
Crossref
Crossref
G.M. Enns, R. Koch, V. Brumm, E. Blakely, R. Suter & E. Jurecki. (2010) Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence. Molecular Genetics and Metabolism 101:2-3, pages 99-109.
Crossref
Crossref
Nenad Blau, Francjan J van Spronsen & Harvey L Levy. (2010) Phenylketonuria. The Lancet 376:9750, pages 1417-1427.
Crossref
Crossref
Greyce Kelly da Silva & Dionísia Aparecida Cusin Lamônica. (2010) Desempenho de crianças com fenilcetonúria no Teste de Screening de Desenvolvimento Denver - II. Pró-Fono Revista de Atualização Científica 22:3, pages 345-350.
Crossref
Crossref
Cynthia A. Riccio, Jeremy R. Sullivan & Morris J. Cohen. 2010. Neuropsychological Assessment and Intervention for Childhood and Adolescent Disorders. Neuropsychological Assessment and Intervention for Childhood and Adolescent Disorders
529
685
.
Patrícia Cotta Mancini, Ana Lúcia Pimenta Starling, Cláudia Fernanda Tolentino Alves, Thaís Maria da Mata Martins & Maria Cecília Martinelli Iório. (2010) Alterações auditivas e fenilcetonúria: uma revisão sistemática. Revista CEFAC 12:1, pages 140-145.
Crossref
Crossref
LOUISE BOTTCHER, ESBEN MEULENGRACHT FLACHS & PETER ULDALL. (2010) Attentional and executive impairments in children with spastic cerebral palsy. Developmental Medicine & Child Neurology 52:2.
Crossref
Crossref
Patrícia Cotta Mancini, Ana Lúcia Pimenta Starling, Letícia Macedo Penna, Camila Alexandra Vilaça Ramos, Michelle Imaculada Otaviani Ferreira & Maria Cecília Martinelli Iório. (2010) Achados audiológicos em crianças com fenilcetonúria. Revista da Sociedade Brasileira de Fonoaudiologia 15:3, pages 383-389.
Crossref
Crossref
Scott D. Grosse. (2010) Late‐Treated Phenylketonuria and Partial Reversibility of Intellectual Impairment. Child Development 81:1, pages 200-211.
Crossref
Crossref
M. H. Beauchamp, V. Anderson & A. Boneh. (2009) Cognitive and social profiles in two patients with cobalamin C disease. Journal of Inherited Metabolic Disease 32:S1, pages 327-334.
Crossref
Crossref
Renzo Manara, Alessandro P. Burlina, Valentina Citton, Mario Ermani, Francesco Vespignani, Carla Carollo & Alberto B. Burlina. (2009) Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria. Neuroradiology 51:12, pages 803-812.
Crossref
Crossref
Dionísia Aparecida Cusin Lamônica, Mariana Germano Gejão, Amanda Tragueta Ferreira, Greyce Kelly da Silva & Fernanda da Luz Anastácio-Pessan. (2009) Desenvolvimento infantil na fenilcetonúria: atuação fonoaudiológica. Revista CEFAC 12:2, pages 326-330.
Crossref
Crossref
Joo-Won Park, Eun-Sook Park, Eun Nam Choi, Hae-Young Park & Sung-Chul Jung. (2009) Altered brain gene expression profiles associated with the pathogenesis of phenylketonuria in a mouse model. Clinica Chimica Acta 401:1-2, pages 90-99.
Crossref
Crossref
F. J. van Spronsen, Marieke Hoeksma & Dirk-Jan Reijngoud. (2009) Brain dysfunction in phenylketonuria: Is phenylalanine toxicity the only possible cause?. Journal of Inherited Metabolic Disease 32:1, pages 46-51.
Crossref
Crossref
Mariana Germano Gejão, Amanda Tragueta Ferreira, Greyce Kelly Silva, Fernanda da Luz Anastácio-Pessan & Dionísia Aparecida Cusin Lamônica. (2009) Communicative and psycholinguistic abilities in children with phenylketonuria and congenital hypothyroidism. Journal of Applied Oral Science 17:spe, pages 69-75.
Crossref
Crossref
J. Meyburg & G. F. Hoffmann. (2008) Liver cell transplantation for the treatment of inborn errors of metabolism. Journal of Inherited Metabolic Disease 31:2, pages 164-172.
Crossref
Crossref
Barbara K. Burton, Álvaro Hermida, Amaya Bélanger-Quintana, Heather Bell, Kendra J. Bjoraker, Shawn E. Christ, Mitzie L. Grant, Cary O. Harding, Stephan C.J. Huijbregts, Nicola Longo, Markey C. McNutt, Mina D. Nguyen-Driver, André L. Santos Pessoa, Júlio César Rocha, Stephanie Sacharow, Amarilis Sanchez-Valle, H. Serap Sivri, Jerry Vockley, Mark Walterfang, Sarah Whittle & Ania C. Muntau. (2022) Management of Early Treated Adolescents and Young Adults with Phenylketonuria: Development of International Consensus Recommendations Using a Modified Delphi Approach. SSRN Electronic Journal.
Crossref
Crossref